PREVIOUS
✖
Shingrix Vaccine
May 2 , 2023
446 days
430
0
- GlaxoSmithKline Pharmaceuticals Ltd. (GSK) announced the launch of its shingles vaccine in India.
- The vaccine, named Shingrix, is one of the best-selling products of the company.
- Shingles is a viral infection that causes a painful rash and it can occur anywhere in the body.
- This is caused by the varicella-zoster virus.
- Shingrix is the world’s first non-live, recombinant subunit vaccine that is given intramuscularly in two doses.
Leave a Reply
Your Comment is awaiting moderation.